Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption
- 1 August 2015
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 101, 348-357
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- Drug repositioning: Re-investigating existing drugs for new therapeutic indicationsJournal of Postgraduate Medicine, 2011
- Targeting mitochondria for cancer therapyNature Reviews Drug Discovery, 2010
- Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell DeathJournal of the American Chemical Society, 2010
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and OpportunitiesAntioxidants & Redox Signaling, 2009
- Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativaCancer Cell International, 2009
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- Role of cell‐cycle regulators in lung cancerJournal of Cellular Physiology, 2005
- Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1Nature, 1995
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990